Concentrix Q2 rev $2.417B (+1.5% YoY) beats guidance; raises FY outlook; EPS $0.63 GAAP, $2.70 non-GAAP

Concentrix Corp

2025-Q2 EPS reported $1.68 vs consensus $2.80 ▼ miss (-40.1%)

Revenue $2,417M (+1.5% YoY) beat guidance; full-year growth outlook raised.
GAAP diluted EPS $0.63 vs $0.98 YoY; non-GAAP diluted EPS $2.70 vs $2.69 (+0.4%).
Adjusted EBITDA $357M (14.8% margin) down 5.9% YoY on temporary program pauses.
Generated $200M adjusted free cash flow in Q2; on track for $625-650M full year.
Board declared $0.33275/sh dividend payable Aug 5, 2025; $45M in share repurchases in Q2.

item 2.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.